Skip to main content
News Jung 09.2021
AG Jung: Julia Steinberg, Timo Wadenpohl, Jun. Prof. Dr. Stephanie Jung
© Katharina Wislsperger / UKB

News categories: Publication

How danger signaling is amplified in Influenza A-virus infected cells

Young research goup around Cluster Member Stephanie Jung shows how danger signaling is amplified in Influenza A-virus infected cells.

Influenza virus-induced acute respiratory infections occur in all parts of the world and represent a constant disease-burden. While the seasonal epidemic outbreaks are caused by Influenza-subtypes A and B, only Influenza-A strains are reported to have caused pandemic spreads. Overall, Influenza-A infections account for 250,000 to 300,000 deaths p.a.

To protect us from microbial threats, the innate immune system provides several immune sensing receptors. These recognize foreign microbial molecules and induce an immunological response. RNA-viruses like Influenza-A and Hepatitis-C are detected by the intracellular receptor RIG-I (retinoic acid inducible gene I). RIG-I binds to double-stranded viral RNA and hairpin structures of viral genomes. Upon activation, the receptor multimerizes and ultimately induces the cellular release of antiviral cytokines.

In a previous publication, Stephanie Jung and colleagues already described the role of endogenous RNA in an amplified RIG-I activation: Recognition of viral RNA by oligoadenylate synthase leads to activation of RNase L, which cleaves endogenous ribosomal RNAs. The resulting fragment acts as endogenous RIG-I ligand (eRL) and thereby amplifies the RIG-I mediated response to the viral thread.

Stephanie Jung and her team now provide evidence that eRL is generated in Influenza-A infected cells. Further they could show that the activation of RIG-I by eRL is independent of the direct recognition of viral RNAs by the receptor. The work thereby provides the foundation for further research on the physiological function of eRLs and their role in other viral infections.

Remarkably, the paper was published only a few months into first-author Julia Steinbergs PhD project, who started her work with Stephanie Jung in April 2021. “Sometimes things just run perfectly – even in the lab” Julia states. It is important to enable young scientists to publish early on during their PhD, Stephanie Jung is convinced. “With her first publication in hand, Julia can now pursue her main project with the maximum freedom possible”.

It is also the first publication for Stephanie Jung as Junior Professor for Cellular Virology and member of the Cluster of Excellence Immunosensation2. As group leader at the institute of Cardiovascular Immunology, her research is focused on the identification of immune-activating viral RNAs and the role of extracellular vesicles in viral infections.


Participating institutions and funding

The project was funded by the German Research Foundation (DFG) under the Germany’s Excellence Strategy – EXC2151 – 390873048.


Publication

Julia Steinberg, Timo Wadenpohl, Stephanie Jung: The Endogenous RIG-I Ligand Is Generated in Influenza A-Virus Infected Cells. Viruses. https://www.mdpi.com/1999-4915/13/8/1564


Contact

Jun. Prof. Dr. Stephanie Jung

University Bonn

University Hospital Bonn

stephanie.jung@ukbonn.de

Related news

The human P2X4 receptor

News categories: Publication

A starting point for the development of new pain and cancer drugs

The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have now discovered a mechanism that can inhibit this receptor. The results were recently published in the scientific journal Nature Communications and open up a pathway for the development of new drugs. A study carried out by the University of Bonn and the University Hospital Bonn throws light on how P2X2 can be inhibited. The results have recently been published in Nature Communications.
View entry
Kato research group

News categories: Publication

Ominous false alarm in the kidney

Bonn researchers have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering a chain reaction. In cooperation with Nanyang Technological University Singapore and the University Hospital Würzburg, among others, the study provides an explanation for how a point mutation in the immune receptor RIG-I transforms the body's defense system into a self-destructive force and causes severe organ-specific autoimmune diseases. The results have now been published in the journal Science Immunology.
View entry
News_Proebstel

News categories: Publication

Unique immune signatures to distinguish MOGAD from MS

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body’s immune system mistakenly attacks the protective myelin sheath of nerve fibers in the central nervous system. Although MOGAD induces symptoms similar to multiple sclerosis (MS), its underlying biology appears to be fundamentally different. Understanding these distinctions is crucial for developing effective, disease-specific treatments. A new international study now sheds light on these immune differences.
View entry

Back to the news overview